Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00043
|
|||||
| Drug Name |
Fructose
|
|||||
| Synonyms |
(3S,4R,5R)-1,3,4,5,6-pentahydroxyhexan-2-one; 30237-26-4; 53188-23-1; 57-48-7; AI3-23514; Apir Levulosa; CCRIS 3335; D(-)-Fructose; D(-)-Fructose, 99%; D-(-)-Fructose; D-(-)-Fructose, > D-(-)-Levulose; D-Levulose; D-fructose; DL-Fructose; EINECS 200-333-3; Fructon; Fructose solution; Fructose, D-; Fructose, pure; Furucton; Hi-Fructo 970; Krystar 300; Levulosa; Levulosa Baxter; Levulosa Braun; Levulosa Ibys; Levulosa Ife; Levulosa Mein; Levulosado Braun; MFCD00148910; Methose; Nevulose; Sugar, fruit; arabino-Hexulose; keto-D-fructose
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Emesis [ICD11: MD90] | Approved | [1] | |||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C6H12O6
|
|||||
| Canonical SMILES |
C(C(C(C(C(=O)CO)O)O)O)O
|
|||||
| InChI |
InChI=1S/C6H12O6/c7-1-3(9)5(11)6(12)4(10)2-8/h3,5-9,11-12H,1-2H2/t3-,5-,6-/m1/s1
|
|||||
| InChIKey |
BJHIKXHVCXFQLS-UYFOZJQFSA-N
|
|||||
| CAS Number |
CAS 57-48-7
|
|||||
| Pharmaceutical Properties | Molecular Weight | 180.16 | Topological Polar Surface Area | 118 | ||
| Heavy Atom Count | 12 | Rotatable Bond Count | 5 | |||
| Hydrogen Bond Donor Count | 5 | Hydrogen Bond Acceptor Count | 6 | |||
| XLogP |
-3.2
|
|||||
| PubChem CID | ||||||
| PubChem SID |
103822107
, 104225898
, 104310785
, 117559373
, 117613538
, 123120957
, 124759816
, 127301939
, 127301940
, 127301941
, 127301942
, 127301943
, 127301944
, 127301945
, 127301946
, 127301947
, 127301948
, 127301949
, 127301950
, 127301951
, 127301952
, 127301953
, 127301954
, 127301955
, 127301956
, 127301957
, 127301958
, 127301959
, 127301960
, 127301961
, 127301962
, 127301963
, 127301964
, 127301965
, 127301966
, 13089
, 14716675
, 15339912
, 16877774
, 29204153
, 29225000
, 46491008
, 46530493
, 49970811
, 57323096
, 68530625
, 75359324
, 7847182
, 8153720
, 92298678
|
|||||
| ChEBI ID |
ChEBI:48095
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | GLUT5 | Transporter Info | Glucose transporter type 5 | Substrate | [2] | |
| GLUT7 | Transporter Info | Glucose transporter type 7 | Substrate | [3] | ||
| SGLT4 | Transporter Info | Sodium/glucose cotransporter 4 | Substrate | [4] | ||
| References | ||||||
| 1 | Fructose was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | Dexamethasone sensitizes the neonatal intestine to fructose induction of intestinal fructose transporter (Slc2A5) function. Endocrinology. 2008 Jan;149(1):409-23. | |||||
| 3 | Functional Properties and Genomics of Glucose Transporters. Curr Genomics. 2007 Apr; 8(2): 113128. | |||||
| 4 | SLC5A9/SGLT4, a new Na+-dependent glucose transporter, is an essential transporter for mannose, 1,5-anhydro-D-glucitol, and fructose. Life Sci. 2005 Jan 14;76(9):1039-50. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.